How Aktiia built the first over-the-counter cuffless blood pressure monitor

Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.

By Elise Reuter • Aug. 20, 2025

NeuroOne gains FDA clearance for trigeminal nerve ablation

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.

By Susan Kelly • Aug. 20, 2025

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

CMR Surgical hires Chris O’Hara to drive US robot expansion

O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization last fall for its Versius system.

By Susan Kelly • Aug. 19, 2025

Medtronic recall of heart vent catheters tied to 3 serious injuries

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being bent.”

By Nick Paul Taylor • Aug. 19, 2025

Heart devices pace medtech’s summer funding flows

July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting new technologies to treat heart conditions.

By Susan Kelly • Aug. 18, 2025

Philips will spend $150M to expand manufacturing for AI-enabled tech

The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, facility.

By Elise Reuter • Aug. 15, 2025

Trump says semiconductor tariffs to come next week

The president indicated that duties on chips would be “approximately 100%” earlier this month.

By Phil Neuffer • Aug. 15, 2025

Apple updates smart watches with blood oxygen feature after customs ruling

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

By Elise Reuter • Aug. 14, 2025

Reprieve Cardiovascular raises $61M; Conformal Medical nets $32M for LAAO

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused companies.

By Susan Kelly • Aug. 14, 2025

Vicarious Surgical delays robot timeline

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by the end of the year.

By Susan Kelly • Aug. 13, 2025

Shan Jegatheeswaran shares J&J’s vision for AI in the OR

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in procedures.

By Elise Reuter • Aug. 13, 2025

Cardiosense appoints John Martin as chief medical officer

The appointment comes weeks after the company received 510(k) clearance for its wearable heart monitor.

By Nick Paul Taylor • Aug. 13, 2025

Draeger removes ventilation filters over misleading carbon dioxide readings

Hospitals are being advised to stop using the filters after serious injuries were reported related to the problem, the FDA said in a recall notice.

By Elise Reuter • Aug. 12, 2025

Heartflow’s IPO raises $364M

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid investor enthusiasm.

By Nick Paul Taylor • Aug. 12, 2025

US to maintain lower tariff rates on China imports for 90 more days

China also extended its suspension of additional retaliatory duties against U.S. goods, maintaining current rates until November.

By Max Garland • Aug. 12, 2025

SetPoint Medical secures $140M to fund neuromodulation for arthritis

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.

By Susan Kelly • Aug. 11, 2025

Apreo raises $130M for pivotal trial of emphysema device

The company, which received investment from the venture capital wing of Intuitive Surgical, has designed the device to work in a broader patient population than existing treatments.

By Nick Paul Taylor • Aug. 11, 2025

Tandem, Insulet monitoring CMS payment proposal for diabetes tech

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.

By Elise Reuter • Aug. 8, 2025

Masimo appoints several senior execs, resolves cyber incident

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but investors have raised questions about the status of a partnership with Philips.

By Susan Kelly • Aug. 8, 2025

Boston Scientific updates instructions of devices linked to 17 deaths

The update covers devices used in procedures to implant the company’s Watchman heart device.

By Nick Paul Taylor • Aug. 8, 2025

Boston Scientific tells users about defibrillator problem linked to deaths, injuries

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.

By Nick Paul Taylor • Aug. 7, 2025

Tandem insulin pump malfunction linked to 59 injuries

 A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.

By Elise Reuter • Aug. 7, 2025

Trump plans 100% tariffs for semiconductor imports

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

By Phil Neuffer • Aug. 7, 2025

BD commits $35M to expand US syringe production plant

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to above 750 million units.

By Nick Paul Taylor • Aug. 6, 2025

FTC moves to block Edwards’ JenaValve acquisition

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

By Susan Kelly • Aug. 6, 2025